Drug profile

The FDA adverse-event record for Decaffeinated Tea Supplement

14 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Decaffeinated Tea Supplement. See the species affected, top reactions, and outcomes below.

14
adverse-event reports
7.1%
death-coded share
Dog
most-reported species
4
Diarrhoea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
1
Deaths Reported
7.1%
Death Rate

Active Ingredients

Decaffeinated Tea Supplement

Administration Routes

UnknownOral

Species Affected

Dog 13
Cat 1

Most Affected Breeds

Pit Bull 2
Bulldog 2
Shepherd Dog - German 1
Dachshund (unspecified) 1
Spaniel - King Charles Cavalier 1
Sheepdog - Shetland 1
Crossbred Canine/dog 1
Havanese 1
Terrier - American Staffordshire 1
Retriever - Labrador 1

Most Reported Reactions

Diarrhoea 4
Not eating 4
Vomiting 3
Bloody diarrhoea 2
Lack of efficacy (endoparasite) - heartworm 2
Loose stool 2
Panting 2
Allergy NOS 2
Azotaemia 2
Abnormal ultrasound finding 2
Other abnormal test result NOS 2
Death 1

Outcome Breakdown

Outcome Unknown
5 (35.7%)
Ongoing
5 (35.7%)
Recovered/Normal
3 (21.4%)
Died
1 (7.1%)

Decaffeinated Tea Supplement Adverse Event Insights

14 reports name Decaffeinated Tea Supplement; 1 recorded a death outcome (7.1% of reported events, not a population-level mortality rate). Active ingredient: Decaffeinated Tea Supplement. Administration routes: Unknown, Oral.

By species: Dog (13 reports), Cat (1 reports). By breed: Pit Bull (2), Bulldog (2), Shepherd Dog - German (1).

Leading clinical signs: Diarrhoea (4), Not eating (4), Vomiting (3), Bloody diarrhoea (2). Outcome, 14 coded reports: Outcome Unknown leads at 35.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.